Clinical Trial Update: A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ribavirin for Acute Myelocytic Leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Ribavirin (ribavirin)

Snippet

Sponsor: Jewish General Hospital | Conditions: Acute Myelocytic Leukemia | Phase 2 | Status: COMPLETED